These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 30806669

  • 1. Determination of the Critical Concentration of Rifabutin for Susceptibility Testing Using the Proportion Method with Löwenstein-Jensen Medium against Mycobacterium Tuberculosis Isolates.
    Dai G, Chen S, Dong L, Li YX, Huo F, Shang Y, Huang H.
    Lab Med; 2019 Jul 16; 50(3):292-297. PubMed ID: 30806669
    [Abstract] [Full Text] [Related]

  • 2. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the rpoB gene of Mycobacterium tuberculosis clinical isolates in Shanghai, PR China.
    Guo Y, Cao X, Yang J, Wu X, Liu Y, Wan B, Hu L, Wang H, Yu F.
    J Med Microbiol; 2021 Mar 16; 70(3):. PubMed ID: 33507146
    [Abstract] [Full Text] [Related]

  • 3. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
    Berrada ZL, Lin SY, Rodwell TC, Nguyen D, Schecter GF, Pham L, Janda JM, Elmaraachli W, Catanzaro A, Desmond E.
    Diagn Microbiol Infect Dis; 2016 Jun 16; 85(2):177-81. PubMed ID: 27036978
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan.
    Chien HP, Yu MC, Ong TF, Lin TP, Luh KT.
    J Formos Med Assoc; 2000 May 16; 99(5):408-11. PubMed ID: 10870331
    [Abstract] [Full Text] [Related]

  • 5. [In vitro study on cross resistance of rifampin and rifapentine for Mycobacterium tuberculosis].
    Duanmu HJ, Liu YH, Jiang GL, Wang SM, Fu YH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar 16; 28(3):192-4. PubMed ID: 15854417
    [Abstract] [Full Text] [Related]

  • 6. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
    Gao L, Xiao HP, Hu ZY, Cui ZL, Lu JM, Shen XN.
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May 16; 35(5):333-5. PubMed ID: 22883990
    [Abstract] [Full Text] [Related]

  • 7. The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.
    Sirgel FA, Warren RM, Böttger EC, Klopper M, Victor TC, van Helden PD.
    PLoS One; 2013 May 16; 8(3):e59414. PubMed ID: 23527189
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Cavusoglu C, Karaca-Derici Y, Bilgic A.
    Clin Microbiol Infect; 2004 Jul 16; 10(7):662-5. PubMed ID: 15214882
    [Abstract] [Full Text] [Related]

  • 9. Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance Signatures of Mycobacterium tuberculosis Is Revealed Using a Whole-Genome Sequencing Assay.
    Yu MC, Hung CS, Huang CK, Wang CH, Liang YC, Lin JC.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0075422. PubMed ID: 35924839
    [Abstract] [Full Text] [Related]

  • 10. Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates.
    Jing W, Pang Y, Zong Z, Wang J, Guo R, Huo F, Jiang G, Ma Y, Huang H, Chu N.
    Front Microbiol; 2017 Aug 31; 8():1768. PubMed ID: 28959248
    [Abstract] [Full Text] [Related]

  • 11. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
    Rastogi N, Goh KS, Berchel M, Bryskier A.
    J Antimicrob Chemother; 2000 Oct 31; 46(4):565-70. PubMed ID: 11020253
    [Abstract] [Full Text] [Related]

  • 12. Molecular detection of rifabutin-susceptible Mycobacterium tuberculosis.
    Chen HY, Yu MC, Huang WL, Wu MH, Chang YL, Che CR, Jou R.
    J Clin Microbiol; 2012 Jun 31; 50(6):2085-8. PubMed ID: 22442316
    [Abstract] [Full Text] [Related]

  • 13. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia.
    Sintchenko V, Chew WK, Jelfs PJ, Gilbert GL.
    Pathology; 1999 Aug 31; 31(3):257-60. PubMed ID: 10503273
    [Abstract] [Full Text] [Related]

  • 14. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
    Barluenga J, Aznar F, García AB, Cabal MP, Palacios JJ, Menéndez MA.
    Bioorg Med Chem Lett; 2006 Nov 15; 16(22):5717-22. PubMed ID: 16987658
    [Abstract] [Full Text] [Related]

  • 15. Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.
    Bakuła Z, Modrzejewska M, Pennings L, Proboszcz M, Safianowska A, Bielecki J, van Ingen J, Jagielski T.
    Antimicrob Agents Chemother; 2018 Apr 15; 62(4):. PubMed ID: 29437627
    [Abstract] [Full Text] [Related]

  • 16. Comparison of rifabutin susceptibility and rpoB mutations in multi-drug-resistant Mycobacterium tuberculosis strains by DNA sequencing and the line probe assay.
    Yoshida S, Suzuki K, Iwamoto T, Tsuyuguchi K, Tomita M, Okada M, Sakatani M.
    J Infect Chemother; 2010 Oct 15; 16(5):360-3. PubMed ID: 20354890
    [Abstract] [Full Text] [Related]

  • 17. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
    Schön T, Juréen P, Chryssanthou E, Giske CG, Kahlmeter G, Hoffner S, Angeby K.
    J Antimicrob Chemother; 2013 Sep 15; 68(9):2074-7. PubMed ID: 23633684
    [Abstract] [Full Text] [Related]

  • 18. Comparison of different methods of assessing in vitro resistance of Mycobacterium tuberculosis to rifampicin.
    Paramasivan CN, Rahman F, Nalini S, Dakshayani G, Venkataraman P.
    Indian J Med Res; 2001 Dec 15; 114():187-91. PubMed ID: 12040761
    [Abstract] [Full Text] [Related]

  • 19. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
    Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y, Maesaki S, Tomono K, Tashiro T, Kohno S.
    J Antimicrob Chemother; 1998 Nov 15; 42(5):621-8. PubMed ID: 9848446
    [Abstract] [Full Text] [Related]

  • 20. Strong in vitro activities of two new rifabutin analogs against multidrug-resistant Mycobacterium tuberculosis.
    García AB, Palacios JJ, Ruiz MJ, Barluenga J, Aznar F, Cabal MP, García JM, Díaz N.
    Antimicrob Agents Chemother; 2010 Dec 15; 54(12):5363-5. PubMed ID: 20855731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.